Cargando…
Sustained interleukin-10 delivery reduces inflammation and improves motor function after spinal cord injury
BACKGROUND: The anti-inflammatory cytokine interleukin-10 (IL-10) has been explored previously as a treatment method for spinal cord injury (SCI) due to its ability to attenuate pro-inflammatory cytokines and reduce apoptosis. Primary limitations when using systemic injections of IL-10 are that it i...
Autores principales: | Hellenbrand, Daniel J., Reichl, Kaitlyn A., Travis, Benjamin J., Filipp, Mallory E., Khalil, Andrew S., Pulito, Domenic J., Gavigan, Ashley V., Maginot, Elizabeth R., Arnold, Mitchell T., Adler, Alexander G., Murphy, William L., Hanna, Amgad S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489327/ https://www.ncbi.nlm.nih.gov/pubmed/31039819 http://dx.doi.org/10.1186/s12974-019-1479-3 |
Ejemplares similares
-
Differences in neuroplasticity after spinal cord injury in varying animal models and humans
por: Filipp, Mallory E., et al.
Publicado: (2019) -
Treating spinal cord injury via sustained drug delivery from calcium phosphate coatings
por: Hellenbrand, Daniel J., et al.
Publicado: (2016) -
Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration
por: Hellenbrand, Daniel J., et al.
Publicado: (2021) -
Glial cell line-derived neurotrophic factor as a treatment after spinal cord injury
por: Ortmann, Stephen D., et al.
Publicado: (2018) -
Gait analysis in swine, sheep, and goats after neurologic injury: a literature review
por: Sveum, Jacob W., et al.
Publicado: (2023)